#USA #Los Angeles #Celiac Disease #Celiac Disease Foundation #Venture Philanthropy

Celiac Disease Foundation Launches Impact Fund

On March 18, 2026, the Celiac Disease Foundation made a significant announcement regarding the launch of the Celiac Disease Foundation Impact Fund. This venture philanthropy fund aims to raise $15 million in its initial phase, targeting innovative solutions within the celiac disease ecosystem. This new initiative marks a pivotal evolution in the Foundation’s strategic approach, shifting from traditional philanthropy to a model that utilizes disciplined investment capital aimed at creating high-impact results for individuals affected by celiac disease.

Managed in collaboration with Triple G Ventures, the Impact Fund is designed to channel resources into scalable innovations across various areas: early detection, prevention, education, and breakthrough therapies. This is essential for closing the persistent gaps that have limited funding and infrastructure in the celiac community, a sector that has seen uneven progress over the years.

A Decisive Shift in Strategy

Marilyn Geller, the CEO of the Foundation, stated, “For over thirty years, we have been at the forefront of research and advocacy, yet the pace of advancement has not kept up with the need.” Celiac disease impacts approximately 1 in 100 individuals globally, with many remaining undiagnosed. The establishment of the Impact Fund represents an essential new method to accelerate progress and transform what is possible for the celiac community.

Investment Focus

The Impact Fund will prioritize four key pillars:
1. Early Detection: Investment in technologies such as at-home diagnostics, AI-driven screening tools, and novel biomarkers.
2. Prevention: Funding research into microbiome-based therapies, immune-modulating strategies, and innovations in pediatric screening.
3. Education & Awareness: Developing digital platforms, training for healthcare providers, certification systems, and scalable community tools to raise awareness.
4. Cures: Supporting research in enzyme therapies, immune tolerance, and gene/cell-based treatments.

The Fund’s overarching goal is to act as a catalyst for change, consistently identifying promising innovations and offering the necessary capital to help scale viable solutions aimed at drastically changing the lives of individuals with celiac disease.

Addressing the Funding Gap

Approximately three million Americans are estimated to suffer from celiac disease, and shockingly, 70% to 80% of these remain undiagnosed. If left untreated, celiac disease can lead to serious complications like osteoporosis, infertility, and even cancer. Despite its significant impact, research funding for celiac disease remains disproportionately lower than other autoimmune conditions.

Geller emphasized, “Patients have waited far too long for substantial investments.” The Impact Fund’s intent is to lay down the necessary infrastructure that drives innovation from diagnostic methods to disease-modifying therapies, ensuring that promising solutions reach affected families promptly.

Sustainable Venture Philanthropy Model

Operating as a mission-driven investment vehicle, the Impact Fund is structured to generate returns that will, in turn, be reinvested back into the fund to support future innovations. This creates a sustainable cycle that not only multiplies philanthropic capital but also enhances efficiency in addressing the funding needs of the celiac community.

To guarantee a prudent investment strategy, an independent committee alongside an advisory network will oversee all portfolio decisions, ensuring each initiative’s scientific rigor and market potential are closely evaluated with patient-centered outcomes in mind.

Gregg Stein, managing partner of Triple G Ventures and Investment Manager of the Celiac Disease Foundation Impact Fund, shared a personal account of celiac disease impact in families, highlighting the urgency of awareness and education. “We are establishing a repeatable engine to identify and fund effective solutions promptly,” he said.

Get Involved

The Impact Fund is currently seeking investment opportunities and building partnerships to enhance contributions to the celiac disease community. Interested investors and supporters are encouraged to contact the Foundation to learn more about how they can be part of this impactful initiative.

About the Celiac Disease Foundation

Founded in 1990, the Celiac Disease Foundation stands as a worldwide leader in advocating for patients and families affected by celiac disease. Through their innovative research investments, public policy outreach, and educational efforts, including the patient registry known as iCureCeliac®, they are dedicated to driving systemic improvements in the diagnosis and treatment of celiac disease.

For additional insights into their initiatives, visit their website at celiac.org.

About Triple G Ventures

Triple G Ventures specializes in providing advisory services and venture strategy to accelerate impactful solutions that align with the mission of the Celiac Disease Foundation, overseeing the operations and portfolio of the Impact Fund.

Join the movement to transform the celiac disease landscape, and be a part of something that’s not just an investment, but a pathway to a healthier and more informed future for millions.